Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 408.00
-8.00 (-1.92%)
Apr 20, 2026, 1:15 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 52.83 billion as of April 17, 2026. Its market cap has decreased by -33.46% in one year.
Market Cap
52.83B
Enterprise Value
68.01B
Revenue
19.01B
Ranking
n/a
PE Ratio
17.90
Stock Price
408.00
Market Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 52.83B, an increase of 1,570.76%. That is a compound annual growth rate of 27.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 52.83B | -12.72% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 242.37B |
| Lotus Pharmaceutical | 61.63B |
| Center Laboratories | 30.16B |
| TTY Biopharm Company | 18.55B |
| Grape King Bio | 17.55B |
| ScinoPharm Taiwan | 17.16B |
| Synmosa Biopharma | 16.06B |
| YungShin Global Holding | 14.97B |